The First Breast Cancer Vaccine to Reach Phase III?
NeuVax CMC Hold Lifted, RXi Gears Up for Phase III
Shares in RXi Pharmaceuticals Corp. (NASDAQ:RXII) jumped 14 percent Monday on news that the FDA had cleared a chemistry, manufacturing and controls (CMC) partial clinical hold on its lead cancer vaccine, NeuVax. Now that the Worcester, Mass.-based company has satisfied all of the FDA's requirements, it is on schedule to begin its Phase III (PRESENT) trial in early 2012.